logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Carboplatin plus etoposide bests topotecan for second-line therapy for SCLC

Topotecan is currently the only second-line therapy approved in Europe for SCLC.